1 Beyond viral suppression of HIV – the new quality of life frontier. JV Lazarus, K Safreed-Harmon, S E. Barton, D Costagliola, N Dedes, J del Amo Valero, JM Gatell, R Baptista-Leite, L Mendão, K Porter, S Vella and JK Rockstroh
BMC Medicine201614:94 Abstract
2 The Global Fund to Fight AIDS, Tuberculosis and Malaria's investments in harm reduction through the rounds-based funding model (2002-2014).
J Bridge, BM Hunter, E Albers,C Cook, M Guarinieri, JV Lazarus, J MacAllister, S McLean, D Wolfe.
Int J Drug Policy. 2016 ;27:132-7. Abstract
3 Are the testing needs of key European populations affected by hepatitis B and C being addressed? A scoping review of testing studies in Europe. JV Lazarus, I Sperle, EF Duffell, A Spina, JK Rockstroh, L Wiessing.
CMJ, 2016;57:442-56. Abstract
4 HMAP, World Hepatitis Day and the bigger health systems picture. JV Lazarus, K Safreed-Harmon, M Maticic.
HMAP, 2016, 2:4. Abstract
5 Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014). JV Lazarus, A Mozalevskis, K Safreed-Harmon, I Eramova I.
HMAP, 2016, 1:3 Abstract